Market Overview

Abaxis, Abbott in Distribution Agreement

Related ABAX
Stocks Hitting 52-Week Highs
UPDATE: Abaxis Reports USDA Approval of VetScan FeLV/FIV Feline Rapid Test
Abaxis (ABAX) Beats Q3 Earnings, Revenues; Margin Grows - Analyst Blog (Zacks)

Abaxis (NASDAQ: ABAX) today announced the Company has signed an exclusive multi-year distribution agreement with Abbott's (NYSE: ABT) Point of Care business to market and distribute the Piccolo Xpress, a portable clinical chemistry system and its full line of one-time use reagent discs to the human medical market.

Under terms of the agreement, Abbott will have the exclusive right to distribute and sell in the U.S. and China (including Hong Kong) Abaxis' Piccolo Xpress chemistry analyzer and associated consumables in the professionally attended human healthcare market. Abaxis will retain the distribution rights to current customer, Catapult Health and certain segments including pharmacy and retail store clinics, shopping malls, contract research organizations (CROs), and cruise ship lines. Abaxis will provide technical support and warranty services to support Abbott's commercial efforts.

Clint Severson, chairman and chief executive officer of Abaxis, said, "We are extremely pleased to have formed a strategic partnership with Abbott to sell and distribute our Piccolo Xpress

See full press release

Posted-In: News Guidance Contracts Management Global


Related Articles (ABAX + ABT)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga Professional